1. Market Research
  2. > Healthcare Market Trends
Medication Adherence Market by Product, by Medication, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

Medication Adherence Market by Product, by Medication, by Geography - Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023

  • November 2017
  • 191 pages
  • ID: 3861584
  • Format: PDF
  • By Prescient & Strategic Intelligence Private Limited

Summary

Table of Contents

Medication adherence market is forecasted to reach $3.6 billion value by 2023, growing at a CAGR of 12.3% during 2017-2023
The growth in the market will be led by the growing demand for advanced medication adherence systems, increasing prevalence of chronic diseases, rising geriatric population, increasing demand for mobile health (mHealth) technologies, and expanding demand for personalized healthcare technologies.

Insights on market segments
In terms of product type, the medication adherence market has been categorized as software centric and hardware centric, where software centric occupied a larger share in the global market in 2016. Hardware centric products are projected to register faster growth during the forecast period, at a CAGR of 13.1%.

This is substantiated by the fact that the major players in the market are focused on launching hardware centric products, such as Smart Wireless Pill Bottles by AdhereTech, Inc., and HealthAssist Watch by Adherence Solutions, LLC, that improve and track adherence in real time.

By medication, the medication adherence market is predicted to be led by demand for the products used for compliance in cardiovascular diseases, both in terms of size and growth. The leading position of the category is due to the increasing cases of cardiovascular diseases across the globe. As per the 2015 global data from WHO, out of 17.7 million deaths caused by cardiovascular diseases, approximately 7.4 million deaths were due to coronary heart disease and 6.7 million were due to stroke.

North America stands as the largest market for medication adherence
North America held the largest medication adherence market share in 2016. This large contribution is mainly driven by the increase in R&D infrastructure, growing aging population, expanding healthcare expenditure, and increasing prevalence of chronic diseases in the region. According to the Centers for Disease Control and Prevention (CDC), the total national healthcare expenditure in the U.S. was $3.2 trillion in 2015 and per capita national health expenditure was $9,990.

Additionally, the healthcare expenditure as a percentage of GDP was 17.8%, and the total investment in R&D (Medical and Health) for 2015 was around $158.7 billion in the U.S.

Major players in the market are launching new and innovative products to gain a larger share
Globally, the key providers in the medication adherence industry are launching new products to gain a larger market share. For instance, in May 2017, DrFirst.com Inc., a clinical software and services provider, announced the launch of SmartSig and PDMP Access Solutions that exemplify intelligent medication management, compliance adherence, and simplification of clinical workflows.

The products offer enhance data quality, improve clinical workflow and deliver stronger adherence to therapy. Both SmartSig and PDMP Access Solutions fully integrate with the company’s suite of intelligent medication management products.

The key players operating in the medication adherence market include Koninklijke Philips N.V., Cardinal Health Inc., Omnicell Inc., McKesson Corporation, Johnson & Johnson Services, Inc., Proteus Digital Health, Inc., AdhereTech Inc., Qualcomm Incorporated, Adherence Solutions LLC, and SMRxT Inc.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Dilated Cardiomyopathy - Pipeline Review, H1 2020

Dilated Cardiomyopathy - Pipeline Review, H1 2020

  • $ 2000
  • January 2020

Dilated Cardiomyopathy - Pipeline Review, H1 2020SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Pipeline Review, H1 2020, provides an overview of the Dilated ...

Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020

"Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Pulmonary Embolism. The marketed ...

Type 2 Angiotensin II Receptor - Pipeline Review, H2 2019

Type 2 Angiotensin II Receptor - Pipeline Review, H2 2019

  • $ 3500
  • December 2019

Type 2 Angiotensin II Receptor - Pipeline Review, H2 2019SummaryType 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) - Angiotensin II receptor type 2 (AT2 receptor) is a protein encoded ...


ref:plp2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on